Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.57 USD | +5.49% | +4.31% | +7.95% |
Business Summary
Number of employees: 214
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Surgical Glaucoma
91.7
%
| 66 | 92.0 % | 74 | 91.7 % | +13.29% |
Dry Eye
8.3
%
| 6 | 8.0 % | 7 | 8.3 % | +17.59% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 71 | 100.0 % | 81 | 100.0 % | +13.63% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Badawi
FOU | Founder | 54 | 09-12-31 |
Paul Badawi
FOU | Founder | 49 | 09-12-31 |
Alison Bauerlein
DFI | Director of Finance/CFO | 42 | 23-04-02 |
Steve R. Tamayo
CMP | Compliance Officer | - | 20-10-31 |
Chris Pike
CTO | Chief Tech/Sci/R&D Officer | - | 19-03-31 |
Daniel O'Keeffe
CTO | Chief Tech/Sci/R&D Officer | - | 11-12-31 |
Ingrid Kane
CTO | Chief Tech/Sci/R&D Officer | - | - |
Reay H. Brown
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sam Park
COO | Chief Operating Officer | 63 | 20-02-29 |
Kathy Chester
LAW | General Counsel | - | 21-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Don Zurbay
BRD | Director/Board Member | 56 | 20-05-31 |
Erica Rogers
BRD | Director/Board Member | 61 | 19-10-31 |
Paul Badawi
FOU | Founder | 49 | 09-12-31 |
Brenda Becker
BRD | Director/Board Member | 64 | 22-03-14 |
Staffan Encrantz
CHM | Chairman | 72 | 16-12-31 |
David Badawi
FOU | Founder | 54 | 09-12-31 |
Director/Board Member | 59 | 23-06-07 | |
Tamara Fountain
BRD | Director/Board Member | 61 | 22-07-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 49,756,252 | 39,495,687 ( 79.38 %) | 0 | 79.38 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.95% | 277M | |
-5.56% | 181B | |
-0.11% | 108B | |
-6.17% | 66.12B | |
+2.64% | 50.65B | |
+6.58% | 43.11B | |
+3.40% | 41.3B | |
+21.98% | 31.6B | |
+16.81% | 25.03B | |
-5.81% | 24.16B |
- Stock Market
- Equities
- SGHT Stock
- Company Sight Sciences, Inc.